Erythroid cells from mice infected with the polycythemia-inducing strain of Friend spleen focus-forming virus (SFFVp), unlike normal erythroid cells, can proliferate and differentiate in the apparent absence of the erythroid hormone erythropoietin (Epo). The unique envelope glycoprotein encoded by SFFV has been shown to be responsible for this biological effect. The recent isolation of an Epo-dependent erythroleukemia cell line, HCD-57, derived from a mouse infected at birth with Friend murine leukemia virus, afforded us the opportunity to study the direct effect of SFFVp on a homogeneous population of factor-dependent cells. The introduction of SFFVp in complex with various helper viruses into these Epo-dependent cells efficiently and reproducibly gave rise to lines which expressed high levels of SFFV and were factor independent. SFFV appears to be unique in its ability to abrogate the factor dependence of Epo-dependent HCD-57 cells, since infection of these cells with retroviruses carrying a variety of different oncogenes had no effect. The induction of Epo independence by SFFV does not appear to involve a classical autocrine mechanism, since there is no evidence that the factor-independent cells synthesize or secrete Epo or depend on it for their growth. However, the SFFV-infected, factor-independent cells had significantly fewer receptors available for binding Epo than their factor-dependent counterparts had, raising the possibility that the induction of factor independence by the virus may be due to the interaction of an SFFV-encoded protein with the Epo receptor.
The Friend strain of the spleen focus-forming virus (SFFV) induces an acute erythroleukemia in mice. Erythroid cells infected with the polycythemia-inducing variant of SFFV (SFFVp) differ from normal erythroid cells in that they can proliferate and differentiate in the apparent absence of the erythroid hormone erythropoietin (Epo) (for a review, see reference 14) . The unique envelope glycoprotein encoded by SFFV has been shown to be responsible for this biological effect (27) . The mechanism by which SFFV alters the growth and differentiation of erythroid cells is unknown.
Spleen cells from SFFVp-infected mice do not secrete detectable amounts of Epo or any other erythroid growth factor (17) and show no change in the number or affinity of Epo receptors (17, 19) . Although the majority of the SFFV envelope glycoprotein is expressed in the cytoplasm, the small amount of protein that is posttranslationally modified and transported to the cell surface appears to be the biologically significant form (9) . Studies with chimeric envelope genes have indicated that specific sequences in the extreme 3' end of the envelope gene which encode the transmembrane portion of the molecule are essential for conferring Epo independence (3, 4) .
The recent isolation of an Epo-dependent erythroleukemia cell line derived from a mouse infected at birth with Friend murine leukemia virus (F-MuLV) (W. D. Hankins Epo-specific RNA transcripts. SFFV-infected FI lines proliferate to high levels in the absence of Epo, whereas the proliferation of the parental line is dependent on the addition of Epo to the medium ( Fig. 2A) . In order to determine if the FI lines make their own Epo, which allows the cells to grow in an autocrinelike manner, we prepared conditioned medium from the cells and assayed them for Epo production with the Epo-dependent parental HCD-57 cells. Conditioned medium from two separate SFFV-infected FT lines failed to release into the medium factors that supported the proliferation of the parental HCD-57 cells (Fig. 2B) . In contrast, conditioned medium from the IW.32 cell line, which has previously been shown to secrete Epo, contained easily detectable amounts of Epo capable of stimulating the HCD-57 cells (data not shown).
Since it was still possible that the SFFV-infected FT cells synthesized Epo but that the factor was not secreted from the cells in detectable amounts, we examined the cells for the presence of Epo-specific RNA transcripts by Northern blot hybridization analysis. The Epo-producing IW.32 cell line displayed high levels of a 1.5-kilobase Epo-specific mRNA (Fig. 3, lanes 3 and 4) . In contrast, no Epo mRNA could be detected in the SFFV-infected FT lines (Fig. 3, lanes  1 and 2) even when Epo sequences were amplified by the polymerase chain reaction (data not shown).
Proliferation of FT (SFFVp) lines is neither density depen- completely inhibited the proliferation of the Epo-dependent parental HCD-57 cells (Fig. 4) (14) and suggests that the mechanism by which this virus induces FI of the HCD-57 cells is indirect, perhaps because of integration of the virus at a specific site in the mouse genome (10, 22 (24) . Results identical to those shown in Table 4 were obtained with a different stock of Abelson MuLV, and both stocks were able to abrogate FDC-P1 cells from their IL-3 dependence as previously described (11) .
The mechanism by which SFFVp induces Epo independence is not known. The virus appears to exert its effect only on erythroid cells; this is supported by the observation that SFFVp had no effect on a variety of IL-3-dependent cell lines (S. Ruscetti, unpublished data). This suggests that SFFV specifically interacts with a component of the Epo signal transduction pathway. Our data indicate that induction of Epo independence by SFFV does not involve a classical autocrine mechanism, since the Fl (SFFVp) cells do not secrete Epo or express Epo mRNA and since their growth is not density dependent or affected by anti-Epo serum. However, it is possible that a product of the SFFV genome interacts with the Epo receptor in such a way that the need for Epo is bypassed. Such an interaction is consistent with our Epo-binding data from the SFFV-infected, Fl cells. These cells contain significantly fewer Epo receptors (four-to sixfold fewer) than the parental line, suggesting that an SFFV protein may interact with the Epo receptor either at the cell surface, which could block Epo binding, or internally, which could block receptor transport to the cell surface. We failed to see this effect of SFFVp in earlier studies with spleen cells from virus-infected mice (17, 19) , most likely because of the heterogeneous nature of the cells and the lack of a clear, uninfected counterpart for comparison. If SFFVp were found to abrogate Epo dependence by directly interacting with the hormone receptor, such an interaction would be a unique mechanism of retroviral transformation. Studies with SFFV-infected, Fl HCD-57 cells and their uninfected factor-dependent counterparts are in progress to further examine the interaction between SFFV gene products and the Epo signal transduction pathway.
